MAV
AMGN icon

Mason & Associates (Virginia)’s Amgen AMGN Stock Holding History

Mason & Associates (Virginia)’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-932
Closed -$265K – 37
2024
Q1 		$265K Buy
+932
New +$273K 0.2% 54

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mason & Associates (Virginia)'s AMGN Position: Q2 2024 in Review

Mason & Associates (Virginia) sold out of Amgen (AMGN) in Q2 2024, closing a stake of 932 shares — an estimated $265K sold.

Mason & Associates (Virginia) first reported a position in AMGN in Q1 2024 and held it in 1 quarter. The position peaked at $265K in Q1 2024. 2,785 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

  • Mason & Associates (Virginia) reported no remaining Amgen position as of Q2 2024 after selling out during the quarter.
  • Mason & Associates (Virginia) sold 932 Amgen shares in Q2 2024, an estimated $265K.
  • Mason & Associates (Virginia) first reported a position in Amgen in Q1 2024 and held it in 1 quarter.
  • Mason & Associates (Virginia)'s Amgen position peaked at $265K in Q1 2024.
  • 2,785 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on Mason & Associates (Virginia)'s 13F filing for Q2 2024, filed 16 Jul 2024.